A Study of IMR-687 in Subjects With Sickle Cell Disease
Public ClinicalTrials.gov record NCT04474314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects With Sickle Cell Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease
Study identification
- NCT ID
- NCT04474314
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 115 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2020 (Actual)
- Primary completion
- Mar 2, 2022 (Actual)
- Completion
- May 4, 2022 (Actual)
- Last update posted
- May 15, 2025
2020 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham School of Medicine - 1917 Clinic | Birmingham | Alabama | 35233 | — |
| Arkansas Primary Care Clinic | Little Rock | Arkansas | 72204 | — |
| University of California San Diego Moores Cancer Center | La Jolla | California | 92093 | — |
| Center For Inherited Blood Disorders | Santa Ana | California | 92705 | — |
| The Oncology Institute Long Beach | Whittier | California | 90603 | — |
| University of Connecticut Health Main Building | Farmington | Connecticut | 06030 | — |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30342 | — |
| The University of Illinois at Chicago College of Medicine | Chicago | Illinois | 60612-4333 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Children's Hospital of Michigan | Detroit | Michigan | 48201 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| Weill Cornell Medicine - Center for Blood Disorders | New York | New York | 10021 | — |
| Baylor Scott & White Medical Center-Temple | Temple | Texas | 76508 | — |
| Virginia Commonwealth University Health - Ambulatory Care Center | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04474314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04474314 live on ClinicalTrials.gov.